Paul Herendeen — Executive Vice President of Finance & CFO at Valeant Pharmaceuticals International

Mr. Paul S. Herendeen has been the Chief Financial Officer and Executive Vice President of Finance at Valeant Pharmaceuticals International, Inc. since August 22, 2016. Mr. Herendeen served as the Chief Financial Officer and Executive Vice President of Zoetis Inc. from September 02, 2014 to August 18, 2016. He served as Principal Financial Officer and Accounting Officer of Warner Chilcott Intermediate (luxembourg) S.A.R.L until 2013. He served as the Chief Financial Officer and Executive Vice President of Warner Chilcott, Inc. from April 1, 2005 to 2013 and served as its Principal Accounting Officer until 2013. He served as Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Warner Chilcott Company, Inc., and Warner Chilcott Holdings Company III, Limited until 2013. Mr. Herendeen served as Chief Financial Officer and Executive Vice President of Warner Chilcott Corp. since April 2005 until 2013 and also served as its Principal Accounting Officer until 2013. He was employed at Carter-Wallace, Inc. He served as the Chief Financial Officer and Executive Vice President of Warner Chilcott PLC since April 1, 2005 until 2013 and also served as its Principal Accounting Officer. From 1998 to March 2001, he served as Executive Vice President and Chief Financial Officer of Warner Chilcott PLC. He was responsible for Warner Chilcott's finance, accounting, treasury and management information system functions. He has more than 30 years of experience in the financial services and healthcare industries. He served as an Executive Vice President and Chief Financial Officer of MedPointe Inc. He served as an Executive Vice President of Galen plc, a public U.K. pharmaceutical company, where he was responsible for business development and management of business relationships with the investment community and investment banks. He served as the Chief Financial Officer and Executive Vice President of Meda Pharmaceuticals, Inc. Mr. Herendeen was employed at Prudential Equity Investors. From 1989 to 1998, he spent nine years as a Principal Investor at both Dominion Income Management Corp. and Cornerstone Partners, where he worked on investments as well as mergers and acquisitions for the firms and their portfolio companies. He also spent the early part of his career in banking and public accounting, having held various positions with the investment banking group of Oppenheimer & Company, the capital markets group of Continental Bank Corporation and as a senior auditor with Arthur Andersen & Company. He was responsible for executing a broad range of investment banking transactions, including public and private market financings, restructuring assignments and financial advisory services. He started his career as an Accountant with Arthur Andersen. He serves as a Director of MedPointe Inc. He served as a Director of Warner Chilcott PLC since 1996 until 2013. He served as Director of Meda Pharmaceuticals, Inc. and of Galen plc. Mr. Herendeen holds a B.S. degree in Business Administration from Boston College and an M.B.A. degree from Colgate Darden Graduate School of Business Administration at the University of Virginia.